H Jeffrey Wilkins - Net Worth and Insider Trading
H Jeffrey Wilkins Net Worth
The estimated net worth of H Jeffrey Wilkins is at least $150 dollars as of 2024-11-13. H Jeffrey Wilkins is the Chief Medical Officer of Avalo Therapeutics Inc and owns about 12 shares of Avalo Therapeutics Inc (AVTX) stock worth over $150. Details can be seen in H Jeffrey Wilkins's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that H Jeffrey Wilkins has not made any transactions after 2021-12-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of H Jeffrey Wilkins
H Jeffrey Wilkins Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, H Jeffrey Wilkins owns 1 companies in total, including Avalo Therapeutics Inc (AVTX) .
Click here to see the complete history of H Jeffrey Wilkins’s form 4 insider trades.
Insider Ownership Summary of H Jeffrey Wilkins
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVTX | Avalo Therapeutics Inc | 2021-12-10 | Chief Medical Officer |
H Jeffrey Wilkins Latest Holdings Summary
H Jeffrey Wilkins currently owns a total of 1 stock. H Jeffrey Wilkins owns 12 shares of Avalo Therapeutics Inc (AVTX) as of December 10, 2021, with a value of $150.
Latest Holdings of H Jeffrey Wilkins
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AVTX | Avalo Therapeutics Inc | 2021-12-10 | 12 | 12.53 | 150 |
Holding Weightings of H Jeffrey Wilkins
H Jeffrey Wilkins Form 4 Trading Tracker
According to the SEC Form 4 filings, H Jeffrey Wilkins has made a total of 2 transactions in Avalo Therapeutics Inc (AVTX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Avalo Therapeutics Inc is the acquisition of 2 shares on December 10, 2021, which cost H Jeffrey Wilkins around $10,003.
Insider Trading History of H Jeffrey Wilkins
- 1
H Jeffrey Wilkins Trading Performance
GuruFocus tracks the stock performance after each of H Jeffrey Wilkins's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by H Jeffrey Wilkins is -42.82%. GuruFocus also compares H Jeffrey Wilkins's trading performance to market benchmark return within the same time period. The performance of stocks bought by H Jeffrey Wilkins within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how H Jeffrey Wilkins's insider trading performs compared to the benchmark.
Performance of H Jeffrey Wilkins
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -27.59 | | | | | |
| Relative Return to S&P 500(%) | -28.69 | | | | | |
H Jeffrey Wilkins Ownership Network
Ownership Network List of H Jeffrey Wilkins
Ownership Network Relation of H Jeffrey Wilkins
H Jeffrey Wilkins Owned Company Details
What does Avalo Therapeutics Inc do?
Who are the key executives at Avalo Therapeutics Inc?
H Jeffrey Wilkins is the Chief Medical Officer of Avalo Therapeutics Inc. Other key executives at Avalo Therapeutics Inc include director & 10 percent owner Armistice Capital Master Fund Ltd. , 10 percent owner Caissa Capital Management Ltd. , and Interim CFO Christopher Ryan Sullivan .
Avalo Therapeutics Inc (AVTX) Insider Trades Summary
Over the past 18 months, H Jeffrey Wilkins made no insider transaction in Avalo Therapeutics Inc (AVTX). Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net purchase of 74,840 shares made by Caissa Capital Management Ltd. , a net sale of 3,683,542 shares made by Armistice Capital Master Fund Ltd. , and a net purchase of 4,000 shares made by Garry Arthur Neil .
In summary, during the past 3 months, insiders sold 0 shares of Avalo Therapeutics Inc (AVTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,348 shares of Avalo Therapeutics Inc (AVTX) were sold and 331 shares were bought by its insiders, resulting in a net sale of 15,017 shares.
Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avalo Therapeutics Inc Insider Transactions
H Jeffrey Wilkins Mailing Address
Above is the net worth, insider trading, and ownership report for H Jeffrey Wilkins. You might contact H Jeffrey Wilkins via mailing address: 600 Lee Road, Suite 100, Wayne Pa 19087.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
